In the last 12 months, insiders at Kalaris Therapeutics made open-market purchases of $6.18 million (724.15K shares) and open-market sales of $12,869 (1.92K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Srinivas Akkaraju | Director, TenPercentOwner | 0 | 12,915,520 | 12,915,520 | 79.3% | 22 May, 2026 |
| 2 | Llc Elevatebio, | Director, TenPercentOwner | 725,019 | 0 | 725,019 | 4.5% | 01 Aug, 2022 |
| 3 | Ansbert Gadicke | Director, TenPercentOwner | 0 | 725,019 | 725,019 | 4.5% | 01 Aug, 2022 |
| 4 | Sciences, Inc. Gilead | TenPercentOwner | 723,302 | 0 | 723,302 | 4.4% | 28 Jun, 2023 |
| 5 | Napoleone Ferrara | Director | 504,000 | 0 | 504,000 | 3.1% | 18 Mar, 2025 |
| 6 | Samir Chandrakant Patel | Director | 252,000 | 100,800 | 352,800 | 2.2% | 18 Mar, 2025 |
| 7 | Juan Vera | Director | 104,784 | 0 | 104,784 | 0.6% | 07 Jun, 2024 |
| 8 | David Hallal | Chief Executive Officer | 93,206 | 0 | 93,206 | 0.6% | 07 Jun, 2024 |
| 9 | Vikas Sinha | Director, Officer, TenPercentOwner | 49,129 | 0 | 49,129 | 0.3% | 24 Feb, 2025 |
| 10 | Diana Brainard | Chief Executive Officer | 31,452 | 0 | 31,452 | 0.2% | 20 Nov, 2024 |
| 11 | Beek Jeroen B Van | Chief Commercial Officer | 14,510 | 0 | 14,510 | 0.1% | 18 Nov, 2022 |
| 12 | Edward Miller | General Counsel | 6,517 | 0 | 6,517 | 0.0% | 24 Feb, 2025 |
| 13 | Cintia Piccina | Chief Commercial Officer | 6,392 | 0 | 6,392 | 0.0% | 05 Jul, 2023 |
| 14 | Ercem Atillasoy | Officer | 5,712 | 0 | 5,712 | 0.0% | 26 Oct, 2022 |
| 15 | Jeffrey S Bornstein | Director | 4,791 | 0 | 4,791 | 0.0% | 07 Jun, 2024 |
| 16 | Morana Jovan-Embiricos | Director, TenPercentOwner | 4,357 | 0 | 4,357 | 0.0% | 07 Jun, 2024 |
| 17 | Malcolm Brenner | Director | 4,357 | 0 | 4,357 | 0.0% | 07 Jun, 2024 |
| 18 | Matthew Feinsod | Chief Medical Officer | 4,030 | 0 | 4,030 | 0.0% | 18 Mar, 2025 |
| 19 | Shawn Tomasello | Director | 3,044 | 0 | 3,044 | 0.0% | 07 Jun, 2024 |
| 20 | Derek N. Adams | Director | 3,044 | 0 | 3,044 | 0.0% | 07 Jun, 2024 |
| 21 | Ann M. Leen | Chief Scientific Officer | 1,870 | 0 | 1,870 | 0.0% | 17 Aug, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 27 Aug, 2026 | Amy O'Leary Vandekop | Vp, Corporate Controller | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 01 Aug, 2026 | Laurie Keating | Director | Acquired A | 18,000 | $0.00 | $0 | 18,000 | Direct |
| 20 Jul, 2026 | Liisa Ann Bayko | Chief Financial Officer | Acquired A | 220,000 | $0.00 | $0 | 220,000 | Direct |
| 03 Jun, 2026 | Napoleone Ferrara | Director | Acquired A | 9,000 | $0.00 | $0 | 9,000 | Direct |
| 03 Jun, 2026 | Morana Jovan-Embiricos | Director | Acquired A | 9,000 | $0.00 | $0 | 9,000 | Direct |
| 03 Jun, 2026 | Srinivas Akkaraju | Director | Acquired A | 9,000 | $0.00 | $0 | 9,000 | Direct |
| 03 Jun, 2026 | Michael Dybbs | Director | Acquired A | 9,000 | $0.00 | $0 | 9,000 | Direct |
| 03 Jun, 2026 | Leone D Patterson | Director | Acquired A | 9,000 | $0.00 | $0 | 9,000 | Direct |
| 03 Jun, 2026 | David Hallal | Director | Acquired A | 9,000 | $0.00 | $0 | 9,000 | Direct |
| 03 Jun, 2026 | Anthony P Adamis | Director | Acquired A | 9,000 | $0.00 | $0 | 9,000 | Direct |
| 20 May, 2026 | Srinivas Akkaraju | Director, TenPercentOwner | Acquired P | 244,300 | $4.83 | $1.18Mn | 2,224,147 | Indirect |
| 20 May, 2026 | Srinivas Akkaraju | Director, TenPercentOwner | Disposed J | 66,906 | $0.00 | $0 | 10,657,028 | Indirect |
| 20 May, 2026 | Srinivas Akkaraju | Director, TenPercentOwner | Acquired J | 14,937 | $0.00 | $0 | 14,937 | Indirect |
| 20 May, 2026 | Srinivas Akkaraju | Director, TenPercentOwner | Acquired J | 4,471 | $0.00 | $0 | 19,408 | Indirect |
| 20 Mar, 2026 | Brett R Hagen | Chief Accounting Officer | Disposed S | 1,915 | $6.72 | $12.87K | 0 | Direct |
| 19 Mar, 2026 | Brett R Hagen | Chief Accounting Officer | Acquired A | 60,800 | $0.00 | $0 | 60,800 | Direct |
| 19 Mar, 2026 | Andrew Oxtoby | Director, Officer | Acquired A | 222,000 | $0.00 | $0 | 222,000 | Direct |
| 19 Mar, 2026 | Matthew Gall | Chief Financial Officer | Acquired A | 95,000 | $0.00 | $0 | 95,000 | Direct |
| 19 Mar, 2026 | Matthew Feinsod | Chief Medical Officer | Acquired A | 135,000 | $0.00 | $0 | 135,000 | Direct |
| 18 Dec, 2025 | Srinivas Akkaraju | Director, TenPercentOwner | Acquired P | 479,847 | $10.42 | $5.00Mn | 1,979,847 | Indirect |